Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for 2019-nCoV pneumonia
RBR-8969zgNot yet recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of acetylcysteine in coronavirus pneumonia, viral pneumonia and severe acute respiratory syndrome (SARS) (2 arms), sponsored by Universidade de São Paulo. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
acetylcysteine
03
Conditions
coronavirus pneumoniaviral pneumoniasevere acute respiratory syndrome (SARS)
Beyond the preview
Go deeper on RBR-8969zg.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8969zg.